Evidence map›Paper›PMID 21156754›Full record

ArticleMolecular pharmacology2011

Functional and biochemical properties of ryanodine receptor type 1 channels from heterozygous R163C malignant hyperthermia-susceptible mice.

Wei Feng, Genaro C Barrientos, Gennady Cherednichenko, Tianzhong Yang, Isela T Padilla, Kim Truong, Paul D Allen, José R Lopez, Isaac N Pessah

Open access · bronzeAbstract read
In one paragraph

Article in Molecular pharmacology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 43 citations in OpenAlex.

  1. Expression of the Human R163C-International journal of molecular sciences · 2026
    Article
  2. Review
  3. Phosphorylation of RYR1 at SerScience signaling · 2025
    Article
  4. EuBiophysical journal · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Wei FengDepartment of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
Genaro C Barrientos
Gennady Cherednichenko
Tianzhong Yang
Isela T Padilla
Kim Truong
Paul D Allen
José R Lopez
Isaac N Pessah
University of California, Davis · USHarvard University Press · US

Funding

Workshop on Environmental Technology Transfer and EntrepreneurshipP42ES004699 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1987 to 2021
$50.1M
Uncovering the Molecular Basis of Malignant HyperthermiaP01AR052354 · NIAMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FRANZINI-ARMSTRONG, CLARA · 2006 to 2016
$13.4M
UC Davis Center for Children's Environmental Health (CCEH)P01ES011269 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI VAN DE WATER, JUDY A. · 2001 to 2018
$12.5M
Molecular and Cellular Basis of PCB Developmental Neurotoxicity: ViCTER supplementR01ES014901 · NIEHS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI HANS-JOACHIM LEHMLER, Pamela J Lein · 2009 to 2026
$9.3M
MOLECULAR &ENVIRONMENTAL FACTORS INFLUENCING MHR01AR046513 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI ALLEN, PAUL D · 2000 to 2003
$2.1M
Molecular and Cellular Basis of PCB Developmental NeurotoxicityR56ES014901 · NIEHS · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEIN, PAMELA J · 2007 to 2007
$150k
NIAMS NIH HHS AR46513NIAMS NIH HHS AR52354NIAMS NIH HHS P01 AR052354NIAMS NIH HHS R01 AR046513NIEHS NIH HHS ES014901NIEHS NIH HHS ES04699NIEHS NIH HHS P01 ES011269NIEHS NIH HHS P42 ES004699NIEHS NIH HHS R01 ES014901NIEHS NIH HHS R56 ES014901
6 · The paper itself

Abstract

Mutations in ryanodine receptor type 1 (RyR1) confer malignant hyperthermia susceptibility. How inherent impairments in Ca(2+) channel regulation affect skeletal muscle function in myotubes and adult fibers under basal (nontriggering) conditions are not understood. Myotubes, adult flexor digitorum brevis (FDB) fibers, and sarcoplasmic reticulum skeletal membranes were isolated from heterozygous knockin R163C and wild-type (WT) mice. Compared with WT myotubules, R163C myotubes have reduced Ca(2+) transient amplitudes in response to electrical field pulses; however, R163C FDB fibers do not differ in their responses to electrical stimuli, despite heightened cellular cytoplasmic resting Ca(2+) ([Ca(2+)](rest)) and sensitivity to halothane. Immunoblotting of membranes from each genotype shows similar expression of RyR1, FK506 binding protein 12 kDa, and Ca(2+)-ATPase, but RyR1 (2844)Ser phosphorylation in R163C muscle is 31% higher than that of WT muscle (p < 0.001). RyR1 channels reconstituted in planar lipid bilayers reveal ∼65% of R163C channels exhibit ≥2-fold greater open probability (P(o)) than WT, with prolonged mean open dwell times and shortened closed dwell times. [(3)H]Ryanodine (Ry) binding and single-channel analyses show that R163C-RyR1 has altered regulation compared with WT: 1) 3-fold higher sensitivity to Ca(2+) activation; 2) 2-fold greater [(3)H]Ry receptor occupancy; 3) comparatively higher channel activity, even in reducing glutathione buffer; 4) enhanced RyR1 activity both at 25 and 37°C; and 5) elevated cytoplasmic [Ca(2+)](rest). R163C channels are inherently more active than WT channels, a functional impairment that cannot be reversed by dephosphorylation with protein phosphatase. Dysregulated R163C channels produce a more overt phenotype in myotubes than in adult fibers in the absence of triggering agents, suggesting tighter negative regulation of R163C-RyR1 within the Ca(2+) release unit of adult fibers.

Indexed as

AnimalsBlotting, WesternCalciumHeterozygoteMalignant HyperthermiaMembrane PotentialsMiceMice, Inbred C57BLMice, Mutant StrainsMuscle Fibers, SkeletalMuscle, SkeletalOxidation-ReductionProtein Phosphatase 1RyanodineRyanodine Receptor Calcium Release ChannelSarcoplasmic Reticulum Calcium-Transporting ATPasesCalciumProtein Phosphatase 1RyanodineRyanodine Receptor Calcium Release ChannelSarcoplasmic Reticulum Calcium-Transporting ATPases

Identifiers

PMID21156754
PMCPMC3061367
OpenAlexW1982717927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.